# Advanced Medical Solutions Group plc (AMS.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Healthcare / Health Care Equipment & Supplies. Price 281p, market value 612 millionp.

## Valuation
- **P/E (trailing): 56.2×** (5-yr avg 4152.7×, 3-yr avg 4587.5×). Advanced Medical Solutions Group plc trades at 56.2× trailing earnings, well below its own five-year average of 4152.7×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 16.6×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.42**. A PEG of 0.42 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.5×**. Each dollar of revenue is priced at 1.5×.
- **Price / book: 2.3×**. The shares trade at 2.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 9.8×**. Enterprise value is 9.8× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 5.8%** (5-yr avg 0.0%). Free cash flow equals 5.8% of the market value, above its five-year average of 0.0%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 1.8%**. The inverse of the P/E: 1.8% of the price is earned each year.

## Profitability
- **Gross margin: 49.6%**. Advanced Medical Solutions Group plc keeps 49.6% of revenue after the direct cost of what it sells.
- **Operating margin: 8.1%**. 8.1% of revenue is left after running the business.
- **Net margin: 4.3%**. 4.3% of each dollar of sales reaches the bottom line.
- **Return on equity: 3.8%**. 3.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 6.3%**. Return on all capital, debt included, is 6.3%.
- **Return on assets: 4.3%**. Each dollar of assets produces 4.3% of profit.

## Growth
- **Revenue growth (1 yr): 29.0%** (3-yr 22.6%/yr, 5-yr 21.4%/yr). Revenue grew 29.0% over the last year, against 21.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 39.1%** (3-yr -21.4%/yr, 5-yr 2.8%/yr). Earnings per share rose 39.1%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 7.7%/yr**. Free cash flow has compounded at 7.7% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.32**. Debt is 0.32 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.9×**. It would take 0.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 3.8×**. Operating profit covers interest 3.8× over, a safe margin.
- **Current ratio: 2.79** (quick 1.39). Current assets cover the next year's liabilities 2.79 times.
- **Altman Z-score: 4.68**. A Z-score of 4.68 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.02%** (0p per share, trailing). Advanced Medical Solutions Group plc yields 1.02%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 58%** (31% of free cash flow). 58% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 13**. 13 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 11.6%/yr** (1-yr 10.3%). The dividend has compounded at 11.6% a year over five years, doubling roughly every 6 years at that pace.
- **Shareholder yield: 1.0%**. Dividends plus net buybacks return 1.0% of the market value a year.

## Price and momentum
- **Total return (1 yr): 34.7%** (YTD 29.1%, 3-mo 28.5%). The shares are up 34.7% over twelve months including dividends.
- **From 52-week high: -1.2%** (50.3% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 61**. An RSI of 61 is neutral.
- **Beta (1 yr): 0.40** (volatility 40%). Beta of 0.40 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AMS.L · Page: https://foliofundamentals.com/stocks/ams.l

Not investment advice.